Systemic delivery of alpha-asarone with Kolliphor HS 15 improves its safety and therapeutic effect on asthma

References

• Aguiar J, Carpena P, Molina-Bolívar JA, Carnero Ruiz C. (2003). On the determination of the critical micelle concentration by the pyrene 1:3 ratio method. J Colloid Interface Sci 258:116–22
   Web of Science ®Google Scholar
• Allen TM, Cullis PR. (2004). Drug delivery systems: entering the mainstream. Science 303:1818–22
   PubMed Web of Science ®Google Scholar
• Antunez-Solis J, Hernandez-Derramadero F, Aquino-Vega M, et al. (2009). 2,4,5-Trimethoxycinnamic acid: the major metabolite of alpha-asarone, retains most of the pharmacological properties of alpha-asarone. J Enzyme Inhib Med Chem 24:903–9
   PubMed Web of Science ®Google Scholar
• Barbero N, Quagliotto P, Barolo C, et al. (2009). Characterization of monomeric and gemini cationic amphiphilic molecules by fluorescence intensity and anisotropy. Part 2. Dyes Pigments 83:396–402
   Web of Science ®Google Scholar
• BASF. (2013). Kolliphor HS 15. Available from: http://www.pharma-ingredients.basf.com [last accessed 22 May 2013]
   Google Scholar
• Bergeron C, Boulet LP. (2006). Structural changes in airway diseases: characteristics, mechanisms, consequenees and pharmacologic modulation. Chest 129:1068–87
   PubMed Web of Science ®Google Scholar
• Burks AW, Sampson HA. (1999). Anaphylaxis and food allergy. Clin Rev Allergy Immunol 17:339–60
   PubMed Web of Science ®Google Scholar
• Burrows B, Martinez FD, Halonen M, et al. (1989). Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 320:271–7
   PubMed Web of Science ®Google Scholar
• Busse WW, Calhoun WF, Sedgewich JD. (1993). Mechanism of airway inflammation in asthma. Am Rev Res Dis 147:S20–4
   PubMed Web of Science ®Google Scholar
• Cai ZQ, Liang Z, Jin H, Mao SJ. (2007). Preparation and quality evaluation of intravenous α-asarone emulsion. West China J Pharm Sci 22:611–13
   Google Scholar
• Chawla JS, Amiji MM. (2002). Biodegradable poly (e-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 249:127–38
   PubMed Web of Science ®Google Scholar
• Daheshia M, Friend DS, Grusby MJ, et al. (2001). Increased severity of local and systemic anaphylactic reactions in Gp49b1-deficient mice. J Exp Med 194:227–34
   PubMed Web of Science ®Google Scholar
• De M, Ghosh P, Rotello V. (2008). Applications of nanoparticles in biology. Adv Mater 20:4225–41
   Web of Science ®Google Scholar
• Farokhzad OC, Cheng J, Teply BA, et al. (2006). Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 103:6315–20
   PubMed Web of Science ®Google Scholar
• Gao Z, Fain HD, Rapoport N. (2004). Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. Mol Pharm 1:317–30
   PubMed Web of Science ®Google Scholar
• Gleich GJ. (2000). Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105:651–63
   PubMed Web of Science ®Google Scholar
• Gou M, Dai M, Li X, et al. (2008). Preparation and characterization of honokiol nanoparticles. J Mater Sci Mater Med 19:2605–8
   PubMed Web of Science ®Google Scholar
• Guo DD, Hou SX, Mao SJ, et al. (2008). Comparison of kinetic behavior in both plasma and tissue after intravenous administration of α-asarone in lipid emulsion and aqueous solution in rats and mice. China J Chin Mater Med 33:46–50
   Google Scholar
• Hennenfent KL, Govindan R. (2006). Novel formulations of taxanes: a review: Old wine in a new bottle. Ann Oncol 17:735–49
   PubMed Web of Science ®Google Scholar
• Lalani T, Simmons RK, Ahmed AR. (1999). Biology of IL-5 in health and disease. Ann Allergy Asthma Immunol 82:317–33
   PubMed Web of Science ®Google Scholar
• Lee HK, Lee HH, Park YM, et al. (1996). Anti-IL-4 antibody inhibits antigen specific IgE response but fails to prevent chicken gamma globulin-induced active systemic anaphylaxis: evidence for the involvement of IgG antibodies. J Korean Med Sci 11:111–17
   PubMedGoogle Scholar
• Lichtenstein LM, Ishizaka K, Norman PS, et al. (1973). IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest 52:472–82
   PubMed Web of Science ®Google Scholar
• Luo X, Wang Q, Zhou L, et al. (2010). Study on relationship between Tween-80 contained in injections of Chinese herbal medicine and anaphylactic reactions. Adv Drug Reactions J 12:160–5
   Google Scholar
• Masini E, Planchenault J, Pezziardi F, et al. (1985). Histamine-releasing properties of Polysorbate 80 in vitro and in vivo: correlation with its hypotensive action in the dog. Agents Actions 16:470–7
   PubMedGoogle Scholar
• Naclerio RM, Adkinson NF, Creticos PS, et al. (1993). Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol 92:717–22
   PubMed Web of Science ®Google Scholar
• Okunuki H, Teshima R, Sakushima J, et al. (2000). Induction of active systemic anaphylaxis by oral sensitization with ovalbumin in mast-cell-deficient mice. Immunol Lett 74:233–7
   PubMed Web of Science ®Google Scholar
• Pollart SM, Chapman MD, Fiocco GP, et al. (1989). Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits. J Allergy Clin Immunol 83:875–82
   PubMed Web of Science ®Google Scholar
• Reed CE. (1994). The importance of eosinophils in the immunology of asthma and allergic disease. Ann Allergy 72:376–80
   PubMedGoogle Scholar
• Ren CJ, Gong T, Sun X, et al. (2011). Alpha-Asarone incorporated in mixed micelles suitable for intravenous administration: formulation, in-vivo distribution and anaphylaxis study. Pharma 66:1–6
   Google Scholar
• Schneider T, van VD, Moqbel R, et al. (1997). Kinetics and quantitation of eosinophil and neutrophil recruitment to allergic lung inflanunation in a brown Norway rat model. Am J Respir Cell Mol Biol 17:702–12
   PubMed Web of Science ®Google Scholar
• Sears MR, Burrows B, Flannery EM, et al. (1991). Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 325:1067–71
   PubMed Web of Science ®Google Scholar
• Tattersfield AE, Knox AJ, Britton JR, Hall IP. (2002). Asthma. Lancet 360:1313–22
   PubMed Web of Science ®Google Scholar
• Underwood SL, Haddad E, Birrell MA, et al. (2002). Functional characterization and biomarker identification in the brown Norway model of allergic airway inflammation. Br J Phannaeol 137:263–75
   PubMed Web of Science ®Google Scholar
• Varma RK, Kaushal R, Junnarkar AY, et al. (1985). Polysorbate 80: a pharmacological study. Arzneimittel Forschung 35:804–8
   PubMed Web of Science ®Google Scholar
• Wu X, Rao WW, Ou Y, Liang ZD. (2010). A brief analysis on ADR monitoring situation of Asarone injection. Chin J Modern Drug Appl 16:9–10
   Google Scholar
• Xu GY, Zhou Y, Zuo GL, Jiang YJ. (2007). An improved procedure for synthesis of alpha-asarone. Org Prep Proc Intern 39:514–17
   Web of Science ®Google Scholar
• Yang LP. (2005). Preparation of alpha-Asarone proliposomes by freeze-drying method. China Pharmacist 8:570–2
   Google Scholar
• Zhao LH, Wu JM, Wu FL. (2007). A review of recent ten-year study on alpha-asarone. Zhongguo Zhong Yao ZaZhi 32:562–5, 650
   PubMedGoogle Scholar
• Zheng C, Mei D, Wang L. (2005). Focused on the adverse effects of formulation excipients. China J Chin Mater Med 40:644–9
   Google Scholar